Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayotunde Omoz-Oarhe, M.B.,B.S.

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ayotunde Omoz-Oarhe's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ayotunde Omoz-Oarhe has written about over time.
Tuberculosis, Pulmonary, 2 publications between 2013 and 2022, average publication date October 2017. AIDS-Related Opportunistic Infections, 1 publications between 2019 and 2019, average publication date March 2019. HIV Infections, 7 publications between 2013 and 2022, average publication date March 2020. Contraceptive Agents, Female, 1 publications between 2020 and 2020, average publication date July 2020. Latent Tuberculosis, 2 publications between 2019 and 2022, average publication date October 2020. Tuberculosis, 4 publications between 2019 and 2022, average publication date January 2021. Antitubercular Agents, 4 publications between 2019 and 2022, average publication date March 2021. Isoniazid, 4 publications between 2019 and 2022, average publication date March 2021. Medroxyprogesterone Acetate, 2 publications between 2020 and 2022, average publication date April 2021. Rifampin, 5 publications between 2019 and 2022, average publication date June 2021. Anti-HIV Agents, 2 publications between 2021 and 2022, average publication date July 2021. Nevirapine, 2 publications between 2021 and 2022, average publication date November 2021. Benzoxazines, 2 publications between 2022 and 2022, average publication date April 2022. Acquired Immunodeficiency Syndrome, 1 publications between 2022 and 2022, average publication date October 2022. Alphapapillomavirus, 1 publications between 2022 and 2022, average publication date October 2022. Papillomavirus Infections, 1 publications between 2022 and 2022, average publication date October 2022. Uterine Cervical Dysplasia, 1 publications between 2022 and 2022, average publication date October 2022. Uterine Cervical Neoplasms, 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Omoz-Oarhe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.